$TGTX Roth Capital Maintains Buy On TG Therapeutics Following Initiation Of Phase I/Ib Combination Study http://www.smarteranalyst.com/2014/12/01/roth-capital-maintains-buy-on-tg-therapeutics-following-initiation-of-phase-iib-combination-study/